WHITEHAWK THERAPEUTICS, INC. Purchase Obligation, to be Paid, Year One
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Purchase Obligation, to be Paid, Year One of $2.70 million as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseObligationDueInNextTwelveMonths · last filed 2025-03-28
- 2024-12-31: Purchase Obligation, to be Paid, Year One $2.70M.
- 2023-12-31: Purchase Obligation, to be Paid, Year One $4.90M.
- 2022-12-31: Purchase Obligation, to be Paid, Year One $1.90M.
| Period end | Purchase Obligation, to be Paid, Year One |
|---|---|
| 2024-12-31 | $2.70M 10-K · filed 2025-03-28 |
| 2023-12-31 | $4.90M 10-K · filed 2024-03-13 |
| 2022-12-31 | $1.90M 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |